Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)

Clinical trial NCT06439602 · COMPLETED

Trial details

NCT number: NCT06439602
Sponsor: Arthrosi Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gout Arthritis, Gouty Hyperuricemia Gout Chronic

Start date: 2024-06-26
Primary completion: 2026-03-20
Enrollment: 818

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.